Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Coivas

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Coivas head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 234 · Grade C

Coivas

Visit Coivas Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Coivas a bad call — it's best for readers comparing ongoing compounded care who will check the full price and unusually detailed guarantee conditions. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
77
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
85
Track Record
88
73
CoreAge RxBrief Score 94 · 66Coivas

Price, coverage & the tracker

CoreAge RxCoivas
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the selected plan

Semaglutide advertised from $119/month; complete supply and commitment require a quote.

The conditional refund guarantee requires six continuous paid months and verified eligibility; it is not a routine cancellation refund.

Full price details

Compounded semaglutide offered; complete selected-plan quote unknown; advertised from $119/month without a full selected supply and commitment

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the selected plan

Tirzepatide advertised from $199/month; complete supply and commitment require a quote.

The conditional refund guarantee requires six continuous paid months and verified eligibility; it is not a routine cancellation refund.

Full price details

Compounded tirzepatide offered; complete selected-plan quote unknown; advertised from $199/month without a full selected supply and commitment

CoverageUS only; restrictions by state, confirmed at intakeFAQ advertises all fifty states; individual medication eligibility remains subject to the independent clinician and pharmacy
Brand-name accessNot confirmedBranded drugs appear as guarantee exclusions, not proof of an available branded prescription offer.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Coivas: From $119/$199 monthly requires a selected-plan quote. The guarantee needs six continuous paid months and verified no weight reduction; it is not a routine cancellation refund.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.